Workflow Solution for illSomatic Mutations


Multiplicom updates its Instructions For Use

Niel, February 21, 1014 - The Instructions For Use (IFU) have been updated to give clear guidance on our general workflow and to include specification for the use of Multiplicom's somatic MASTRs. For a list of the most critical changes, please refer to the Update Notification.

Multiplicom expands its range of MASTR kits

Niel, December 2, 2013 – Multiplicom NV, a specialist in the development, production and commercialization of innovative molecular genetic tests based on massively parallel sequencing (MPS), today announces that it is launching a CE/IVD labeled MID kit for Illumina® MiSeq® together with three new germline mutation detection MASTRTM kits enabling the identification of individuals at risk for maturity onset diabetes of the young (MODY), autosomal dominant hypercholesterolemia (ADH), and hypertrophic cardiomyopathy (HCM).